Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents

Bioorganic & Medicinal Chemistry Letters
2016.0

Abstract

Various 1,3,4-oxadiazole derivatives have been synthesized and their antiproliferative properties have been studied. The in vitro screening was performed against androgen dependent (LNCaP) and androgen independent (PC-3) prostate cancer cell lines. Most of the compounds showed promising activity. Among them, compounds 2d (IC50=0.22 and 1.3μM) and 2a (IC50=8.34 and 2,5μM) have shown significant activities on PC-3 and LNCaP cell lines respectively. To investigate the mechanism of cell death we performed cell apoptosis staining and cell cycle arrest assay on more sensitive PC-3 cell lines on 2d. The results demonstrated that 2d induced apoptosis and shifted the cells to the sub G0/G1 and S phase. Our study evidently identified the potency of compound 2d as potential anti-prostate cancer agent.

Knowledge Graph

Similar Paper

Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents
Bioorganic & Medicinal Chemistry Letters 2016.0
1,2,4-Oxadiazoles: A new class of anti-prostate cancer agents
Bioorganic & Medicinal Chemistry Letters 2012.0
Novel indazole skeleton derivatives containing 1,2,3-triazole as potential anti-prostate cancer drugs
Bioorganic & Medicinal Chemistry Letters 2022.0
Design, synthesis and apoptosis inducing effect of novel (Z)-3-(3′-methoxy-4′-(2-amino-2-oxoethoxy)-benzylidene)indolin-2-ones as potential antitumour agents
European Journal of Medicinal Chemistry 2016.0
Oxazolidinone derivatives: Cytoxazone–Linezolid hybrids induces apoptosis and senescence in DU145 prostate cancer cells
European Journal of Medicinal Chemistry 2014.0
Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists
Bioorganic & Medicinal Chemistry Letters 2017.0
Synthesis and anticancer evaluation of new lipophilic 1,2,4 and 1,3,4-oxadiazoles
European Journal of Medicinal Chemistry 2019.0
Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer
Bioorganic & Medicinal Chemistry Letters 2004.0
Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents
European Journal of Medicinal Chemistry 2019.0
Biological Mechanisms of Action of Novel C-10 Non-Acetal Trioxane Dimers in Prostate Cancer Cell Lines
Journal of Medicinal Chemistry 2006.0